参考文献/References:
[1] Freddie B, Jacques F, Isabelle S, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin.2018,68(2):394-424.
[2] 宋学红.宫颈癌前病变:三阶梯诊疗程序筛查诊治宫颈癌前病变[J]. 中国实用妇科与产科杂志, 2007,23(7):499-501.
[3] Jennifer S, Noel T B, Debbie S, et al.Recommendations for a national agenda to substantially reduce cervical cancer[J]. Cancer Causes & Control Ccc, 2013, 24(8):1583-1593.
[4] Chen W Q, Zheng R S,Bade P D,et al.Cancer statistics in China[J]. Ca Cancer J Clin,2015,66(2):115-132.
[5] Joy M, James N, Andrew R W, et al.Natural history of cervical squamous intraepithelial lesions: a meta-analysis[J]. Obstet Gynecol,1998, 92(4):727-735.
[6] Arbyn M, Roelens J, Cuschieri K, et al.The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy[J]. Int J Cancer, 2013, 132(1):101-108.
[7] Hedman E, Thompson P, Hansen K.Compliance With Asccp Guidelines for Evaluation and Management of Abnormal Pap Smears [28e][J]. Obstetrics & Gynecology, 2017, 129(5):59S.
[8] De Sanjose S,Quint W G,Alemany L,et al.Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[J]. Lancet Oncology, 2010, 11(11):1048-1056.
[9] Saslow D,Solomon D,Lawson H W,et al.ACS-ASCCP-ASCP Cervical Cancer Guideline Committee.American Cancer Society,American Society for Colposcopy and Cervical Pathology,and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer [J]. CA Cancer J Clin,2012,62:147-172.
[10] Farkas S A,Nina M G,Grace M,et al.Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer [J]. Epigenetics,2014,8:1213-1225.
[11] Lai H C,Lin Y W,Huang T H,et al.Identification of novel DNA methylation markers in cervical cancer [J]. Int J Cancer,2008,123(1):161-167.
[12] Kong L Y,Du W,Wang L,et al.PAX1 methylation hallmarks promising accuracy for cervical cancer screening in asians:results from a meta-analysis [J]. Clin Lab,2015,61(10):1471.
[13] Liou, Y L, Zhang T L,Yan T,et al.Combined clinical and genetic testing algorithm for cervical cancer diagnosis[J]. Clinical Epigenetics, 2018,8(1):66.
[14] 黄勉, 林珺, 沈张,等.PAX1基因启动子甲基化用于子宫颈癌临床应用价值探讨[J]. 中南药学, 2019, 17(4):142-147.
[15] Wu N Y Y, Zhang X, Chu T, et al.High methylation of ZNF582 in cervical adenocarcinoma affects radiosensitivity and prognosis[J]. Ann Transl Med, 2019, 7(14): 328.
[16] Tian Y, Wu N Y Y, Liou Y L, et al.Utility of gene methylation analysis, cytological examination, and HPV-16/18 genotyping in triage of high-risk human papilloma virus-positive women[J]. 2017, 8(37):62274-62285.
[17] Lai H C,Lin Y W,Huang R L,et al.Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse [J]. Cancer,2010,116:4266-4274.
[18] Fang C, Wang S Y, Liou Y L, et al.The promising role of PAX1(aliases: HUP48, OFC2)gene methylation in cancer screening[J]. Mol Genet Genomic Med, 2019, 7(3): e506
[19] 王燕, 潘一红, 章月桃, 等.高危HPV感染者心理状况及个性化护理干预效果分析[J].中国现代医生, 2019, 57(15):
[20] Chao T K,Ke F Y,Liao Y P,et al.Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1(PAX1)[J]. Diagn Cytopathol, 2013, 41(1):41-46.
[21] Liou Y L,Zhang T L,Tian Y,et al.Combined clinical and genetic testing algorithm for cervical cancer diagnosis [J]. Clin Epigenetics, 2016, 8(1): 66.